Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin/Ezetimibe vs High-intensity Statin in Older CAD Patients Undergoing PCI
NCT07626840Not yet recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jun 2026
- Primary completion
- Jun 2028
01
Overview
Randomised trial of pitavastatin and ezetimibe in coronary artery disease (CAD) and acute coronary syndrome (ACS) (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Major Adverse Cardiovascular Events at 2 years. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
pitavastatinezetimibe
03
Conditions
coronary artery disease (CAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07626840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626840.